Hutchmed (HCM) is up 10.4%, or $1.70 to $18.07.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCM:
- Hutchmed’s Phase III Study on HMPL-306: A Potential Game-Changer for AML Treatment
- HUTCHMED (China) Buy Rating: Strategic Growth Amidst Market Challenges
- Hutchmed Reports Strong Interim Results Amid Strategic Growth
- Hutchmed reports 1H EPS $2.61 vs. 15c last year
- Hutchmed sees FY25 Oncology/Immunology revenue $270M-$350M